Long-term and continuous administration of Bacillus subtilis during remission effectively maintains the remission of inflammatory bowel disease by protecting intestinal integrity, regulating epithelial proliferation, and reshaping microbial structure and function

The long-term and continuous administration of Bacillus subtilis in remission phase could effectively maintain the remission of IBD by improving the intestinal microenvironment, particularly the gut microbiota and corresponding metabolites.